Bridging the Gap for ALS and Chronic Kidney Disease Act of 2025; enact
HB 323 ensures individuals under 65 with disabilities, like ALS and chronic kidney disease, gain equitable access to Medicare supplement policies in Georgia.
HB 323 ensures individuals under 65 with disabilities, like ALS and chronic kidney disease, gain equitable access to Medicare supplement policies in Georgia.
Bill Number: HB 323
Introduced: February 06, 2025
Status: Senate Read and Referred
Classification: Bill
House Bill 323, titled the "Bridging the Gap for ALS and Chronic Kidney Disease Act of 2025," aims to amend existing laws regarding Medicare supplement insurance in Georgia. The primary intent of the bill is to ensure that individuals under 65 years of age who are eligible for Medicare due to disability or end-stage renal disease receive equitable access to Medicare supplement policies. This legislation seeks to eliminate disparities in insurance coverage based on age, particularly for those suffering from conditions like Amyotrophic Lateral Sclerosis (ALS) and chronic kidney disease.
The bill proposes several significant changes to Chapter 43 of Title 33 of the Official Code of Georgia Annotated, including:
Eligibility Expansion:
Open Enrollment Periods:
Premium Rate Regulations:
Guaranteed Renewability:
Preexisting Condition Limitations:
Regulatory Oversight:
Implementation Timeline:
This legislation is expected to significantly benefit individuals under 65 years of age who are living with disabilities or chronic illnesses, particularly ALS and chronic kidney disease. By providing access to Medicare supplement policies without age-based discrimination, the bill aims to improve healthcare coverage and financial security for these vulnerable populations.
This summary provides an overview of HB 323, highlighting its purpose, key provisions, and potential impact on individuals affected by ALS and chronic kidney disease in Georgia.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.